<DOC>
	<DOCNO>NCT00003621</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Radiation therapy use high-energy x-rays damage tumor cell . Combining one drug radiation therapy may kill tumor cell . PURPOSE : Phase II trial study effectiveness combination chemotherapy plus radiation therapy treat patient newly diagnose anaplastic astrocytoma .</brief_summary>
	<brief_title>Combination Chemotherapy Plus Radiation Therapy Treating Patients With Anaplastic Astrocytoma</brief_title>
	<detailed_description>OBJECTIVES : I . Determine efficacy carmustine , cisplatin , etoposide give prior radiotherapy patient anaplastic astrocytoma . II . Assess toxic effect associate regimen patient . III . Evaluate regimen term fatigue , depression , excessive daytime somnolence , quality life patient . OUTLINE : Patients receive carmustine IV 1 hour day 1-3 , oral etoposide day 1-21 29-49 , cisplatin IV 1-2 hour day 1-3 29-31 . Treatment repeat every 8 week 3 course . Patients receive radiotherapy concurrently third course chemotherapy . Quality life assess every 4 month 1 year , every 6 month 4 year , annually 5 year . Patients follow every 3 month 5 year annually thereafter . PROJECTED ACCRUAL : A total 28 patient accrue study within 20 month .</detailed_description>
	<mesh_term>Astrocytoma</mesh_term>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<mesh_term>Etoposide phosphate</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Etoposide</mesh_term>
	<mesh_term>Carmustine</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm , newly diagnose , anaplastic astrocytoma No oligodendrogliomas oligoastrocytomas PATIENT CHARACTERISTICS : Age : 18 Performance status : ECOG 02 Life expectancy : Not specify Hematopoietic : WBC least 3500/mm3 Platelet count least 130,000/mm3 Hepatic : Bilirubin great 1.5 time upper limit normal ( ULN ) SGOT great 2 time ULN Renal : Creatinine great 0.5 mg/dL Other : Not pregnant nursing Fertile patient must use effective contraception No uncontrolled infection No concurrent malignant disease major medical problem except superficial skin cancer PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : At least 5 year since prior chemotherapy Endocrine therapy : Concurrent corticosteroid allow Radiotherapy : At least 5 year since prior radiotherapy Surgery : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>120 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>adult anaplastic astrocytoma</keyword>
</DOC>